SCHEMBL21099641

SCHEMBL21099641

CC(C)(NN)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18881181 0.78
SCHEMBL4288201 0.75
SCHEMBL2190290 0.75
SCHEMBL5415498 0.75
SCHEMBL10992058 0.73 LMNA (0.32)
SCHEMBL8257534 0.73
Hydrochloric Acid SCHEMBL27762047 0.73
SCHEMBL13588069 0.73
SCHEMBL19867154 0.73
SCHEMBL21898698 0.71 CYP1A2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021250531-A1 4-(4,5-DIHYDRO-1H-PYRAZOL-1-YL)PYRIMIDINE COMPOUND AS CANNABINOID RECEPTOR (CB1 RECEPTOR) ANTAGONISTS AND PHARMACEUTICAL COMPOSITION INCLUDING SAME 주식회사 종근당 2021-12-16 WO disclosed
CN-109952295-A A kind of CDK4/6 inhibitor and its preparation method and application 江苏豪森药业集团有限公司 2019-06-28 CN disclosed
EP-2986313-B1 STABLE, PROTRACTED GLP-1/GLUCAGON RECEPTOR CO-AGONISTS FOR MEDICAL USE NOVO NORDISK AS (DK) 2019-06-12 EP disclosed